179 related articles for article (PubMed ID: 31839163)
1. Is prophylactic mastectomy justified in women without BRCA mutation?
Rutgers EJT
Breast; 2019 Nov; 48 Suppl 1():S62-S64. PubMed ID: 31839163
[TBL] [Abstract][Full Text] [Related]
2. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
3. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
5. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic counseling on the uptake of contralateral prophylactic mastectomy among younger women with breast cancer.
Terkelsen T; Rønning H; Skytte AB
Acta Oncol; 2020 Jan; 59(1):60-65. PubMed ID: 31379231
[No Abstract] [Full Text] [Related]
7. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
8. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer after a diagnosis of ovarian cancer in BRCA mutation carriers: Is preventive mastectomy warranted?
McGee J; Giannakeas V; Karlan B; Lubinski J; Gronwald J; Rosen B; McLaughlin J; Risch H; Sun P; Foulkes WD; Neuhausen SL; Kotsopoulos J; Narod SA;
Gynecol Oncol; 2017 May; 145(2):346-351. PubMed ID: 28314588
[TBL] [Abstract][Full Text] [Related]
10. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
[TBL] [Abstract][Full Text] [Related]
11. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
[TBL] [Abstract][Full Text] [Related]
12. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
[TBL] [Abstract][Full Text] [Related]
13. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
14. Contralateral prophylactic mastectomy in breast cancer: what to discuss with patients.
Montagna G; Morrow M
Expert Rev Anticancer Ther; 2020 Mar; 20(3):159-166. PubMed ID: 32077338
[No Abstract] [Full Text] [Related]
15. Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics.
Schott S; Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Dikow N; Evers C; Sohn C; Heil J
Arch Gynecol Obstet; 2017 Jun; 295(6):1451-1458. PubMed ID: 28439664
[TBL] [Abstract][Full Text] [Related]
16. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
19. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
20. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
Kenny R; Reed M; Subramanian A
Int J Surg; 2018 Feb; 50():60-64. PubMed ID: 29288115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
